Great! Now that I’ve reviewed the full PDF including the results, figures, tables, and discussion, I’ll revise and finalize your **Results Section Slides** based on the actual document structure and data visuals. Here's a slide-by-slide breakdown that maintains clarity, data depth, and aligns tightly with your narrative:

---

### 🎯 **Slide 1: Study Population Overview**

**Title:** *Baseline Characteristics and Sample Overview*

* **Total Participants**: 1,988

  * Nairobi: 1,101
  * Agincourt: 887
* **Inclusion Criteria**:

  * No diabetes diagnosis or fasting glucose ≥ 7 mmol/L at Phase I
* **Diabetes Onset (Phase II)**:

  * 218 (11%) developed diabetes

    * Nairobi: 108
    * Agincourt: 110

---

### 📊 **Slide 2: Binary Classification Results**

**Title:** *Binary Outcome Modeling & Performance Metrics*

* **Models Used**: Logistic Regression, SVM, Gradient Boosting, XGBoost
* **Best AUC**: 0.73 (XGBoost)
* **F1 Scores**: Low across all (best: 0.38)
* **Precision**: Poor (0.20–0.28)
* **Recall**: 0.50–0.61

📌 *Observation*: Models misclassified many **false positives** (people flagged diabetic but were not).

* **Figure Included**: Histograms of false positives showing elevated glucose (5–6.9 mmol/L)

---

### 🔄 **Slide 3: Motivation for Target Redefinition**

**Title:** *Identifying Pre-diabetes: Why Binary Was Insufficient*

* False positives had **elevated glucose**, likely **pre-diabetic**, not truly non-diabetic
* Re-defined target into:

  * Class 0: Non-diabetic (< 5.6 mmol/L)
  * Class 1: Pre-diabetic (5.6–6.9 mmol/L)
  * Class 2: Diabetic (≥ 7.0 mmol/L)

📊 *Transition Insight*:

* 24% of pre-diabetics → diabetic
* 8% of non-diabetics → diabetic

**Included Table**: Class transitions (Table 3.0.3)

---

### ⚖️ **Slide 4: Multiclass Model Evaluation**

**Title:** *Improved Precision with Multiclass Approach*

* **Models Used**: One-vs-Rest with same four algorithms
* **Best Precision**: 0.45 (SVM)
* **F1 Scores**: Improved (up to 0.45)
* **AUC**: 0.65–0.68 range

📌 *Outcome*: Significant reduction in false positives; better differentiation of risk

---

### 🧬 **Slide 5: Feature Comparison Across Classes**

**Title:** *Baseline Variable Differences (3-Class Comparison)*

* **Significant Differences (ANOVA)**:

  * **Age, BRI, MAP, Triglycerides, Glucose, LDL, Weight**
* **Pre-diabetics** had:

  * Higher MVPA, ACR
  * Similar HDL and Age to diabetics
* **Diabetics** had the highest medians in most variables

**Visuals**: Consider including simplified boxplots or key stats table

---

### 💡 **Slide 6: SHAP-Based Model Interpretation**

**Title:** *SHAP Explainability of XGBoost Predictions*

* **Top Feature Across Classes**: Fasting Glucose
* **Diabetic & Non-diabetic**:

  * Influential: Age, BRI, Weight
* **Pre-diabetic**:

  * More influenced by: HOMA, MVPA, eGFR, HIV status

📌 *Unique Findings*:

* **HIV status** appeared important for pre-diabetes
* **Body composition (BRI/Weight)** less relevant for pre-diabetics than other groups

**Included Plots**: SHAP Summary Plots for 3 Classes

---

### ✅ **Slide 7: Summary of Results**

**Title:** *Key Takeaways*

* Binary classification **overlooked pre-diabetes**, reducing clinical utility
* Reclassification revealed:

  * Better model precision and interpretability
  * High-risk characteristics of pre-diabetics
* SHAP helped validate biologically plausible risk patterns
* Findings support **reviewing diagnostic thresholds** and **targeting pre-diabetics**

---

Would you like these slides exported into:

* **PowerPoint (.pptx)**
* **PDF presentation**
* **LaTeX Beamer format**
* **Google Slides (shareable link)**?

You're absolutely right — in binary classification, you're used to seeing a **single SHAP summary plot** showing feature impacts on the prediction of class 1 (e.g., diabetic). But in **multiclass classification**, like the one shown here, **each class gets its own SHAP plot**. Here's how to read this **trio of SHAP plots** for the **XGBoost multiclass model**:

---

## 🔍 **What This Figure Shows**

**Each SHAP plot (left, center, right)** corresponds to one class:

* **Left:** Non-diabetic (Class 0)
* **Middle:** Pre-diabetic (Class 1)
* **Right:** Diabetic (Class 2)

Each plot answers:

> *“Which features most influence the model in assigning a person to this class?”*

---

## 🧠 **How to Read Each Plot**

### X-Axis:

* **SHAP value**: Impact of that feature on the prediction for this specific class.

  * **Positive SHAP** → pushes prediction **toward** that class.
  * **Negative SHAP** → pushes prediction **away from** that class.

### Y-Axis:

* Features (ordered by average importance for this class)

### Color:

* **Red = high actual value**
* **Blue = low actual value**

---

## 🔍 **Interpretation by Class**

### 🔵 **Non-Diabetic (Left Plot)**

* **Top predictor:** `glucose_result_phase1`

  * Low glucose (blue) → strongly pushes toward non-diabetic
* **BRI, age, weight**:

  * Lower values (blue) → increase non-diabetic prediction
* So, healthier profiles lead to **positive SHAP values** → correctly predicted non-diabetic

---

### 🟡 **Pre-Diabetic (Middle Plot)**

* **Glucose still dominates**, but **less separation** than in diabetic plot
* Features like **HOMA, MAP, MVPA, ACR** become more relevant here

  * Moderate values (magenta) often contribute to pre-diabetes classification
* **HIV status, site, alcohol use**: appear as more class-specific factors

🧠 *This class is nuanced: values are often between healthy and high-risk.*

---

### 🔴 **Diabetic (Right Plot)**

* Again, **glucose is the strongest driver**

  * High glucose (red) → strongly pushes to diabetic class
* **HOMA, BRI, age, weight, triglycerides**:

  * Higher values (red) → increase SHAP → push prediction to diabetic class
* **MAP and HDL** have moderate impact too

---

## 🧭 **Why This Matters in Multiclass Context**

You’re no longer asking:

> “Why did the model predict diabetic?”

Instead, you're asking:

> “Why did the model assign this person to *this* class over the other two?”

So for each class:

* SHAP explains **which features** make a person more or less likely to fall into that class.
* You see **class-specific risk signatures**.

---

## ✅ Summary

| Class        | Key Driving Features                                | SHAP Impact Summary         |
| ------------ | --------------------------------------------------- | --------------------------- |
| Non-Diabetic | Low glucose, low BRI, younger age                   | These reduce predicted risk |
| Pre-Diabetic | Moderate glucose, HOMA, MAP, ACR, HIV, site factors | Transitional risk profile   |
| Diabetic     | High glucose, BRI, HOMA, weight, triglycerides      | High metabolic risk profile |

Let me know if you’d like me to create a slide summarizing this visual for your presentation.
